Loading organizations...
Loading organizations...
Specialty formulations from human milk for critically ill infants.
Prolacta Bioscience has raised $75.9M across 5 funding rounds.
Prolacta Bioscience has raised $75.9M in total across 5 funding rounds.
Prolacta Bioscience has raised $75.9M in total across 5 funding rounds.
Prolacta Bioscience's investors include Aisling Capital, Health Evolution Partners, David Brailer, Alison de Bord, Arcturus Capital, DFJ Frontier, DFJ Mercury, Draper Associates, Funk Ventures, Gideon Hixon Fund, Phillip Capital, Draper Richards.
Prolacta Bioscience has raised $75.9M across 5 funding rounds. Most recently, it raised $8.9M Other Equity in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 15, 2018 | $8.9M Other Equity | ||
| Dec 6, 2016 | $35.0M Debt | Aisling Capital, Health Evolution Partners | |
| Nov 3, 2011 | $15.0M Series D | David Brailer | |
| May 23, 2007 | $12.0M Other Equity | Alison de Bord | Arcturus Capital, DFJ Frontier, DFJ Mercury, Draper Associates, Funk Ventures, Gideon Hixon Fund, Phillip Capital |
| Oct 4, 2006 | $5.0M Series B | Arcturus Capital, DFJ Frontier, DFJ Mercury, Draper Associates, Draper Richards, Funk Ventures, Gideon Hixon Fund, Phillip Capital |